Live Breaking News & Updates on Transcode Therapeutics Inc

Stay updated with breaking news from Transcode therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TransCode Therapeutics' (RNAZ) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $3.00 target price on the stock. TransCode Therapeutics Stock Performance TransCode Therapeutics stock opened at $1.78 on Wednesday. TransCode Therapeutics has a 52-week low of $0.42 […] ....

Virtu Financial , Transcode Therapeutics Inc , Transcode Therapeutics , Free Report , Code Therapeutics , Get Free Report , Transcode Therapeutics Daily ,

TransCode Therapeutics (NASDAQ:RNAZ) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $3.00 target price on the stock. TransCode Therapeutics Stock Performance NASDAQ:RNAZ opened at $1.78 on Wednesday. The firm has a market cap of $11.75 million, a […] ....

Transcode Therapeutics Inc , Sabby Management , Securities Exchange Commission , Transcode Therapeutics , Free Report , Code Therapeutics , Get Free Report , Transcode Therapeutics Daily ,

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel ...

BOSTON, May 29, 2024 (GLOBE NEWSWIRE) TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced new preliminary data ....

United States , Tania Montgomery Hammon , Daniel Vlock , Zdravka Medarova , Exchange Commission , Transcode Therapeutics Inc , Business Development , Code Therapeutics , Chief Scientific Officer , Chief Medical , Private Securities Litigation Reform Act , Investigational New Drug , Annual Report ,

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Daniel Vlock , Tania Montgomery Hammon , Zdravka Medarova , Transcode Therapeutics Inc , Business Development , Exchange Commission , Code Therapeutics Reports Positive Data , Code Therapeutics , Chief Scientific Officer , Chief Medical , Private Securities Litigation Reform Act , Investigational New Drug , Annual Report ,

TransCode Therapeutics Reports Positive Data from

TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138 . ....

United States , Tania Montgomery Hammon , Daniel Vlock , Zdravka Medarova , Exchange Commission , Business Development , Transcode Therapeutics Inc , Code Therapeutics , Chief Scientific Officer , Chief Medical , Private Securities Litigation Reform Act , Investigational New Drug , Annual Report ,